128 related articles for article (PubMed ID: 35784533)
1. Fufang Zhenzhu Tiaozhi Capsule Prevents Intestinal Inflammation and Barrier Disruption in Mice With Non-Alcoholic Steatohepatitis.
Lan T; Xu T; Fu Y; Jiang S; Liang X; Yu Z; Pan L; Rong X; Guo J
Front Endocrinol (Lausanne); 2022; 13():864703. PubMed ID: 35784533
[TBL] [Abstract][Full Text] [Related]
2. Chaihu Guizhi Ganjiang Decoction attenuates nonalcoholic steatohepatitis by enhancing intestinal barrier integrity and ameliorating PPARα mediated lipotoxicity.
Wu H; Lou T; Pan M; Wei Z; Yang X; Liu L; Feng M; Shi L; Qu B; Cong S; Chen K; Yang H; Liu J; Li Y; Jia Z; Xiao H
J Ethnopharmacol; 2024 May; 326():117841. PubMed ID: 38310988
[TBL] [Abstract][Full Text] [Related]
3. Tangshen formula targets the gut microbiota to treat non-alcoholic fatty liver disease in HFD mice: A 16S rRNA and non-targeted metabolomics analyses.
Wang S; Li X; Zhang B; Li Y; Chen K; Qi H; Gao M; Rong J; Liu L; Wan Y; Dong X; Yan M; Ma L; Li P; Zhao T
Biomed Pharmacother; 2024 Apr; 173():116405. PubMed ID: 38484559
[TBL] [Abstract][Full Text] [Related]
4. Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling.
Kotsiliti E; Leone V; Schuehle S; Govaere O; Li H; Wolf MJ; Horvatic H; Bierwirth S; Hundertmark J; Inverso D; Zizmare L; Sarusi-Portuguez A; Gupta R; O'Connor T; Giannou AD; Shiri AM; Schlesinger Y; Beccaria MG; Rennert C; Pfister D; Öllinger R; Gadjalova I; Ramadori P; Rahbari M; Rahbari N; Healy ME; Fernández-Vaquero M; Yahoo N; Janzen J; Singh I; Fan C; Liu X; Rau M; Feuchtenberger M; Schwaneck E; Wallace SJ; Cockell S; Wilson-Kanamori J; Ramachandran P; Kho C; Kendall TJ; Leblond AL; Keppler SJ; Bielecki P; Steiger K; Hofmann M; Rippe K; Zitzelsberger H; Weber A; Malek N; Luedde T; Vucur M; Augustin HG; Flavell R; Parnas O; Rad R; Pabst O; Henderson NC; Huber S; Macpherson A; Knolle P; Claassen M; Geier A; Trautwein C; Unger K; Elinav E; Waisman A; Abdullah Z; Haller D; Tacke F; Anstee QM; Heikenwalder M
J Hepatol; 2023 Aug; 79(2):296-313. PubMed ID: 37224925
[TBL] [Abstract][Full Text] [Related]
5. Paeonol attenuates nonalcoholic steatohepatitis by regulating intestinal flora and AhR/NLRP3/Caspase-1 metabolic pathway.
Yan G; Zhang L; Wu D; Jiang S; Wu Q; Dai M
J Ethnopharmacol; 2024 Jul; 329():118147. PubMed ID: 38574779
[TBL] [Abstract][Full Text] [Related]
6. Fufang Zhenzhu Tiaozhi (FTZ) suppression of macrophage pyroptosis: Key to stabilizing rupture-prone plaques.
Shao X; Zeng W; Wang Q; Liu S; Guo Q; Luo D; Luo Q; Wang D; Wang L; Zhang Y; Diao H; Piao S; Yan M; Guo J
J Ethnopharmacol; 2024 Apr; 324():117705. PubMed ID: 38219878
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticles alleviate non-alcoholic steatohepatitis via ER stress sensor-mediated intestinal barrier damage and gut dysbiosis.
Zhu M; Cheng Y; Tang Y; Li S; Rao P; Zhang G; Xiao L; Liu J
Front Microbiol; 2023; 14():1271835. PubMed ID: 38516345
[TBL] [Abstract][Full Text] [Related]
8. Modulating sphingosine 1-phosphate receptor signaling skews intrahepatic leukocytes and attenuates murine nonalcoholic steatohepatitis.
Liao CY; Barrow F; Venkatesan N; Nakao Y; Mauer AS; Fredrickson G; Song MJ; Sehrawat TS; Dasgupta D; Graham RP; Revelo XS; Malhi H
Front Immunol; 2023; 14():1130184. PubMed ID: 37153573
[TBL] [Abstract][Full Text] [Related]
9.
Jiang FY; Yue SR; Tan YY; Tang N; Xu YS; Zhang BJ; Mao YJ; Xue ZS; Lu AP; Liu BC; Wang RR
Nutrients; 2024 Jun; 16(11):. PubMed ID: 38892715
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-582-3p knockdown alleviates non-alcoholic steatohepatitis by altering the gut microbiota composition and moderating TMBIM1.
Huang S; Xiao X; Wu H; Zhou F; Fu C
Ir J Med Sci; 2024 Apr; 193(2):909-916. PubMed ID: 37823951
[TBL] [Abstract][Full Text] [Related]
11. Anti-steatotic effects of PPAR-alpha and gamma involve gut-liver axis modulation in high-fat diet-fed mice.
Vasques-Monteiro IML; Fernandes-da-Silva A; Miranda CS; Silva-Veiga FM; Daleprane JB; Souza-Mello V
Mol Cell Endocrinol; 2024 May; 585():112177. PubMed ID: 38373652
[TBL] [Abstract][Full Text] [Related]
12. Antibiotics attenuate diet-induced nonalcoholic fatty liver disease without altering intestinal barrier dysfunction.
Brandt A; Csarmann K; Hernández-Arriaga A; Baumann A; Staltner R; Halilbasic E; Trauner M; Camarinha-Silva A; Bergheim I
J Nutr Biochem; 2024 Jan; 123():109495. PubMed ID: 37871765
[TBL] [Abstract][Full Text] [Related]
13. Dual-Stimuli-Responsive Gut Microbiota-Targeting Nitidine Chloride-CS/PT-NPs Improved Metabolic Status in NAFLD.
Lu J; Zeng Y; Zhong H; Guo W; Zhang Y; Mai W; Qin Y; Su X; Zhang B; Wu W; Zhu Y; Huang Q; Ye Y
Int J Nanomedicine; 2024; 19():2409-2428. PubMed ID: 38476281
[TBL] [Abstract][Full Text] [Related]
14. Semaglutide alters gut microbiota and improves NAFLD in db/db mice.
Mao T; Zhang C; Yang S; Bi Y; Li M; Yu J
Biochem Biophys Res Commun; 2024 May; 710():149882. PubMed ID: 38583231
[TBL] [Abstract][Full Text] [Related]
15. Foodborne Carbon Dots Aggravate High-Fat-Diet-Induced Glucose Homeostasis Imbalance by Disrupting the Gut-Liver Axis.
Zhang B; Yu Z; Zhao X; He T; Fan X; Zhu R; Feng Y; Lu W; Qi D; Ma X; Gu N
ACS Appl Mater Interfaces; 2024 Mar; 16(10):12263-12276. PubMed ID: 38421240
[TBL] [Abstract][Full Text] [Related]
16. Artemisia argyi ethanol extract ameliorates nonalcoholic steatohepatitis-induced liver fibrosis by modulating gut microbiota and hepatic signaling.
Erdenebileg S; Kim M; Nam Y; Cha KH; Le TT; Jung SH; Nho CW
J Ethnopharmacol; 2024 Jun; 333():118415. PubMed ID: 38848971
[TBL] [Abstract][Full Text] [Related]
17. Intestinal Barrier Dysfunction and Gut Microbiota in Non-Alcoholic Fatty Liver Disease: Assessment, Mechanisms, and Therapeutic Considerations.
Long C; Zhou X; Xia F; Zhou B
Biology (Basel); 2024 Apr; 13(4):. PubMed ID: 38666855
[TBL] [Abstract][Full Text] [Related]
18. Gualou-Xiebai-Banxia-Tang regulates liver-gut axis to ameliorate Metabolic Syndrome in HFD-fed mice.
Zhang Y; Zhang L; Li Z; Liu X; He P; Gu Y; Liu L; Jin Y; Cheng S; Zhou F; Jia Y
Phytomedicine; 2024 Jan; 132():155320. PubMed ID: 38901285
[TBL] [Abstract][Full Text] [Related]
19. High-fat diet induces sarcopenic obesity in natural aging rats through the gut-trimethylamine N-oxide-muscle axis.
Mo X; Cheng R; Shen L; Sun Y; Wang P; Jiang G; Wen L; Li X; Peng X; Liao Y; He R; Yan H; Liu L
J Adv Res; 2024 May; ():. PubMed ID: 38744403
[TBL] [Abstract][Full Text] [Related]
20. The Efficacy and Safety of Chinese Medicine Fufang Zhenzhu Tiaozhi Capsule (FTZ) in the Treatment of Diabetic Coronary Heart Disease: Study Protocol for Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Wang L; Xiang L; Piao S; Gong X; Zhou W; Feng W; Li H; Li L; Wei A; Zhu Q; Rong X; Guo J
Diabetes Metab Syndr Obes; 2021; 14():2651-2659. PubMed ID: 34163193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
